meddevicedb.com FDA Device Reference

STAR Apollo™ Mapping System

K253733 Class II Special
Decision Date
2025-12-19
Sponsor / Applicant
Rhythm AI, Ltd.

Technical Specification

510(k) Submission ID K253733
Product Code DQK
Medical Specialty / Panel Cardiovascular
Regulation Citation 21 CFR 870.1425
Decision Date 2025-12-19
Clearance Pathway Special

Official Documentation

FDA CDRH Summary / statement of record

View FDA Summary PDF

Clearance Summary

STAR Apollo™ Mapping System received FDA 510(k) clearance under submission number K253733, sponsored by Rhythm AI, Ltd.. The device was reviewed via the Special premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2025-12-19.

Classification & Regulation

This clearance is catalogued under FDA product code DQK and 21 CFR 870.1425, within the Cardiovascular review panel as a Class II device.